Safeguarding the Global Supply of Medicines
Eroding Patient Confidence in Biologic Medicines
Safeguarding the Global Supply of Medicines
Eroding Patient Confidence in Biologic Medicines
previousnext

Pharmaceutical Manufacturing in LMICs: Where Things Go Wrong

Root Causes of Substandard Medicines

In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.

Share
0

Developing Quality Standards for Metal Packaging Used in Drug Products

Standards for Metal Packaging

Desmond Hunt, Ph.D., USP’s Senior Scientific Liaison, provides insight into metal packaging systems for drugs and how USP standards can support quality in this field. Dr. Hunt works closely with USP’s Expert Committee on Packaging and Distribution—the volunteer experts who serve as key decision-makers in the USP standards-setting process. Learn more.

 
Share
0

Safeguarding the Global Supply of Medicines Including Biologics

Safeguarding the Global Supply of Medicines Including Biologics

Today, many critical, life-saving medicines go through a complex global supply chain before ever reaching the patient. USP’s public standards play important roles throughout that supply chain. Learn more.

Share
0

Pages

Related Stories

Letter to Senate on Biologics Quality
Industry, payers & pharmacy groups support USP in opposing removal of quality standard requirement for biologics.
USP Standards for Plastic Packaging Systems for Drugs
USP Q&A: Standards for Plastic Packaging Systems for Drug Products
New Standards for Handling Hazardous Drugs Help Protect Personnel & Patients
Handling Hazardous Drugs Is about Protecting Healthcare Personnel and Patients
What the Letters "USP" Mean on the Label of Your Medicine